Cargando…

Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening

BACKGROUND: The aim of this study was to analyse breast cancer incidence and mortality in Tyrol from 1970 to 2006, namely after performing more than a decade of opportunistic mammography screening and just before piloting an organised screening programme. Our investigation was conducted on a populat...

Descripción completa

Detalles Bibliográficos
Autores principales: Oberaigner, Willi, Buchberger, Wolfgang, Frede, Thomas, Knapp, Rudolf, Marth, Christian, Siebert, Uwe
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843664/
https://www.ncbi.nlm.nih.gov/pubmed/20170536
http://dx.doi.org/10.1186/1471-2458-10-86
_version_ 1782179247768469504
author Oberaigner, Willi
Buchberger, Wolfgang
Frede, Thomas
Knapp, Rudolf
Marth, Christian
Siebert, Uwe
author_facet Oberaigner, Willi
Buchberger, Wolfgang
Frede, Thomas
Knapp, Rudolf
Marth, Christian
Siebert, Uwe
author_sort Oberaigner, Willi
collection PubMed
description BACKGROUND: The aim of this study was to analyse breast cancer incidence and mortality in Tyrol from 1970 to 2006, namely after performing more than a decade of opportunistic mammography screening and just before piloting an organised screening programme. Our investigation was conducted on a population level. METHODS: To study time trends in breast cancer incidence and mortality, we applied the age-period-cohort model by Poisson regression to the official mortality data covering more than three decades from 1970 to 2006 and to the incidence data ranging from 1988 to 2006. In addition, for incidence data we analysed data on breast cancer staging and compared these with EU guidelines. RESULTS: For the analysis of time trend in breast cancer mortality in age groups 40-79, an age-period-cohort model fits well and shows for years 2002-2006 a statistically significant reduction of 26% (95% CI 13%-36%) in breast cancer mortality as compared to 1992-1996. We see only slight non-significant increases in breast cancer incidence. For the past five years, incidence data show a 10% proportion of in situ cases, and of 50% for cases in stages II+. CONCLUSIONS: The opportunistic breast cancer screening programme in Tyrol has only in part exploited the mortality reduction known for organised screening programmes. There seems to be potential for further improvement, and we recommend that an organised screening programme and a detailed screening database be introduced to collect all information needed to analyse the quality indicators suggested by the EU guidelines.
format Text
id pubmed-2843664
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28436642010-03-23 Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening Oberaigner, Willi Buchberger, Wolfgang Frede, Thomas Knapp, Rudolf Marth, Christian Siebert, Uwe BMC Public Health Research article BACKGROUND: The aim of this study was to analyse breast cancer incidence and mortality in Tyrol from 1970 to 2006, namely after performing more than a decade of opportunistic mammography screening and just before piloting an organised screening programme. Our investigation was conducted on a population level. METHODS: To study time trends in breast cancer incidence and mortality, we applied the age-period-cohort model by Poisson regression to the official mortality data covering more than three decades from 1970 to 2006 and to the incidence data ranging from 1988 to 2006. In addition, for incidence data we analysed data on breast cancer staging and compared these with EU guidelines. RESULTS: For the analysis of time trend in breast cancer mortality in age groups 40-79, an age-period-cohort model fits well and shows for years 2002-2006 a statistically significant reduction of 26% (95% CI 13%-36%) in breast cancer mortality as compared to 1992-1996. We see only slight non-significant increases in breast cancer incidence. For the past five years, incidence data show a 10% proportion of in situ cases, and of 50% for cases in stages II+. CONCLUSIONS: The opportunistic breast cancer screening programme in Tyrol has only in part exploited the mortality reduction known for organised screening programmes. There seems to be potential for further improvement, and we recommend that an organised screening programme and a detailed screening database be introduced to collect all information needed to analyse the quality indicators suggested by the EU guidelines. BioMed Central 2010-02-20 /pmc/articles/PMC2843664/ /pubmed/20170536 http://dx.doi.org/10.1186/1471-2458-10-86 Text en Copyright ©2010 Oberaigner et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Oberaigner, Willi
Buchberger, Wolfgang
Frede, Thomas
Knapp, Rudolf
Marth, Christian
Siebert, Uwe
Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening
title Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening
title_full Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening
title_fullStr Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening
title_full_unstemmed Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening
title_short Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening
title_sort breast cancer incidence and mortality in tyrol/austria after fifteen years of opportunistic mammography screening
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843664/
https://www.ncbi.nlm.nih.gov/pubmed/20170536
http://dx.doi.org/10.1186/1471-2458-10-86
work_keys_str_mv AT oberaignerwilli breastcancerincidenceandmortalityintyrolaustriaafterfifteenyearsofopportunisticmammographyscreening
AT buchbergerwolfgang breastcancerincidenceandmortalityintyrolaustriaafterfifteenyearsofopportunisticmammographyscreening
AT fredethomas breastcancerincidenceandmortalityintyrolaustriaafterfifteenyearsofopportunisticmammographyscreening
AT knapprudolf breastcancerincidenceandmortalityintyrolaustriaafterfifteenyearsofopportunisticmammographyscreening
AT marthchristian breastcancerincidenceandmortalityintyrolaustriaafterfifteenyearsofopportunisticmammographyscreening
AT siebertuwe breastcancerincidenceandmortalityintyrolaustriaafterfifteenyearsofopportunisticmammographyscreening